We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Infectious Diseases – News and Features

News

Researchers Found Lung Stem Cells

Study shows the lung stem cells was an important target of SARS viruses in a "Decapitation Strike" like attack toward against lungs.
News

Developments Improve Safety of Stem Cell Transplantation in the Treatment of Leukaemia

Study shows that a 'suicide' gene can be used to cut short rejection reactions following stem cell transplants.
News

Researchers Identify Roles of Gene Mutations Causing Lupus in Mice

Researchers find that a defect in the Ly108 gene causes immune cells called B-cells to attack the body’s healthy cells.
News

Montford Point Marine Association Announces Support of Missouri Stem Cell Research and Cures Initiative

The Initiative protects the right of Missouri patients to have their diseases and injuries treated with any stem cell cures and therapies.
News

Covance Announces the Acquisition of Signet Laboratories

Covance acquires substantially all of the assets of Signet Laboratories.
News

Carrington Receives European Patent Protection for Stabilization of Proteins and Peptides

Focuses on stabilization of unstable molecules expands drug delivery base for proteins and peptides.
News

Human Genome Sciences Completes Transaction Establishing CoGenesys as an Independent Company

CoGenesys will focus on the early development of selected gene-based product opportunities.
News

Inovio at ASGT 9th Annual Meeting

Inovio’s presentation showcase potential for electroporation in delivering DNA vaccines.
News

Fluidigm Topaz® System Expedites Structure Determination for the Hemagglutinin of the H5N1 Avian flu Virus

The goal of this research was to identify mutations that can permit influenza A viruses to cross the species barrier and adapt to a new host.
News

Experimental flu Vaccine Bypasses Needles by Patricia Reaney

PowderMed says it would move into bigger tests of its vaccine, which uses DNA from the flu virus to stimulate immunity.
Advertisement